BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
BVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. BVS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
BVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
BVS has a Return On Assets of -4.57%. This is in the better half of the industry: BVS outperforms 66.84% of its industry peers.
BVS has a better Return On Equity (-21.34%) than 60.43% of its industry peers.
BVS's Return On Invested Capital of 3.71% is fine compared to the rest of the industry. BVS outperforms 73.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROIC | 3.71% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a better Operating Margin (4.27%) than 69.52% of its industry peers.
In the last couple of years the Operating Margin of BVS has declined.
BVS has a Gross Margin of 67.45%. This is in the better half of the industry: BVS outperforms 74.33% of its industry peers.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
BVS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BVS has been increased compared to 5 years ago.
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that BVS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BVS (0.97) is comparable to the rest of the industry.
BVS has a debt to FCF ratio of 14.89. This is a negative value and a sign of low solvency as BVS would need 14.89 years to pay back of all of its debts.
The Debt to FCF ratio of BVS (14.89) is better than 73.26% of its industry peers.
BVS has a Debt/Equity ratio of 2.15. This is a high value indicating a heavy dependency on external financing.
BVS has a worse Debt to Equity ratio (2.15) than 86.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Altman-Z | 0.97 |
ROIC/WACC0.38
WACC9.67%
2.3 Liquidity
A Current Ratio of 1.43 indicates that BVS should not have too much problems paying its short term obligations.
The Current ratio of BVS (1.43) is worse than 78.07% of its industry peers.
A Quick Ratio of 0.89 indicates that BVS may have some problems paying its short term obligations.
BVS has a Quick ratio of 0.89. This is amonst the worse of the industry: BVS underperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.45%, which is quite impressive.
BVS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.93% yearly.
BVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.59%.
Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)45.45%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)8.59%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-4.31%
3.2 Future
Based on estimates for the next years, BVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.79% on average per year.
BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.48% yearly.
EPS Next Y51.86%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue Next Year0.05%
Revenue Next 2Y3.03%
Revenue Next 3Y3.48%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.52, the valuation of BVS can be described as correct.
87.17% of the companies in the same industry are more expensive than BVS, based on the Price/Earnings ratio.
BVS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.21.
Based on the Price/Forward Earnings ratio of 7.78, the valuation of BVS can be described as very cheap.
Based on the Price/Forward Earnings ratio, BVS is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
BVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.52 | ||
| Fwd PE | 7.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 86.63% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 85.56% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.93 | ||
| EV/EBITDA | 12.26 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BVS's earnings are expected to grow with 19.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y38.04%
EPS Next 3Y19.79%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.97
+0.35 (+5.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.8%
Inst Owner Change5.04%
Ins Owners2.55%
Ins Owner Change4.79%
Market Cap572.52M
Analysts77.14
Price Target15.3 (119.51%)
Short Float %2.08%
Short Ratio2.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)158.87%
Min EPS beat(2)78.22%
Max EPS beat(2)239.51%
EPS beat(4)4
Avg EPS beat(4)149.48%
Min EPS beat(4)78.22%
Max EPS beat(4)239.51%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.37%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)4.79%
Revenue beat(4)3
Avg Revenue beat(4)4.21%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)8.81%
Revenue beat(8)7
Avg Revenue beat(8)4.85%
Revenue beat(12)9
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)2.19%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.56%
EPS NY rev (1m)7.61%
EPS NY rev (3m)7.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.52 | ||
| Fwd PE | 7.78 | ||
| P/S | 1.01 | ||
| P/FCF | 23.93 | ||
| P/OCF | 22.48 | ||
| P/B | 3.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.26 |
EPS(TTM)0.48
EY6.89%
EPS(NY)0.9
Fwd EY12.85%
FCF(TTM)0.29
FCFY4.18%
OCF(TTM)0.31
OCFY4.45%
SpS6.91
BVpS1.8
TBVpS-3.11
PEG (NY)0.28
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROCE | 4.69% | ||
| ROIC | 3.71% | ||
| ROICexc | 3.88% | ||
| ROICexgc | 21.12% | ||
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% | ||
| FCFM | 4.21% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score4
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Debt/EBITDA | 4.3 | ||
| Cap/Depr | 3.1% | ||
| Cap/Sales | 0.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 34.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 0.97 |
F-Score4
WACC9.67%
ROIC/WACC0.38
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.45%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y51.86%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue 1Y (TTM)8.59%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-4.31%
Revenue Next Year0.05%
Revenue Next 2Y3.03%
Revenue Next 3Y3.48%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year20.58%
EBIT Next 3Y13.24%
EBIT Next 5YN/A
FCF growth 1Y3671.34%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y155.46%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%